La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

eHealth Croissance future

Future contrôle des critères 0/6

eHealth devrait augmenter ses bénéfices et son chiffre d'affaires de 66% et de 6.6% par an respectivement. Le BPA devrait croître de de 57.2% par an. Le rendement des capitaux propres devrait être -3.6% dans 3 ans.

Informations clés

66.0%

Taux de croissance des bénéfices

57.2%

Taux de croissance du BPA

Insurance croissance des bénéfices	9.2%
Taux de croissance des recettes	6.6%
Rendement futur des capitaux propres	-3.6%
Couverture par les analystes	Low
Dernière mise à jour	13 Aug 2024

Mises à jour récentes de la croissance future

Recent updates

Positive Sentiment Still Eludes eHealth, Inc. (NASDAQ:EHTH) Following 25% Share Price Slump

Aug 30

We Think Some Shareholders May Hesitate To Increase eHealth, Inc.'s (NASDAQ:EHTH) CEO Compensation

Jun 06

eHealth Inc.: Upside Awaits For Patient Investors

May 21

Market Cool On eHealth, Inc.'s (NASDAQ:EHTH) Revenues Pushing Shares 27% Lower

Apr 16

eHealth, Inc. (NASDAQ:EHTH) Just Reported, And Analysts Assigned A US$8.36 Price Target

Mar 01

Time To Worry? Analysts Just Downgraded Their eHealth, Inc. (NASDAQ:EHTH) Outlook

Aug 11

eHealth falls 9% as stock hits 52-week low

Jul 11

eHealth: Wrestling With The Balance Sheet And Costs

Apr 29

Bearish: Analysts Just Cut Their eHealth, Inc. (NASDAQ:EHTH) Revenue and EPS estimates

Mar 03

Prévisions de croissance des bénéfices et des revenus

NasdaqGS:EHTH - Estimations futures des analystes et données financières antérieures (USD Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
12/31/2026	569	-9	N/A	N/A	1
12/31/2025	510	-25	-1	5	4
12/31/2024	482	-30	-18	-7	4
6/30/2024	471	-72	-31	-19	N/A
3/31/2024	472	-66	-8	3	N/A
12/31/2023	453	-67	-17	-7	N/A
9/30/2023	402	-96	-3	8	N/A
6/30/2023	390	-95	-8	3	N/A
3/31/2023	374	-108	-27	-13	N/A
12/31/2022	405	-119	-42	-27	N/A
9/30/2022	453	-171	-128	-111	N/A
6/30/2022	463	-184	-171	-152	N/A
3/31/2022	509	-162	-178	-158	N/A
12/31/2021	538	-123	-183	-163	N/A
9/30/2021	588	-24	-179	-157	N/A
6/30/2021	618	22	-106	-85	N/A
3/31/2021	611	41	-97	-74	N/A
12/31/2020	583	45	-132	-108	N/A
9/30/2020	591	74	-91	-68	N/A
6/30/2020	567	78	-107	-85	N/A
3/31/2020	544	75	-95	-75	N/A
12/31/2019	506	67	-88	-71	N/A
9/30/2019	339	4	-38	-23	N/A
6/30/2019	310	6	-27	-12	N/A
3/31/2019	277	0	-14	-1	N/A
12/31/2018	251	0	-14	-3	N/A
9/30/2018	200	2	-14	-5	N/A
6/30/2018	190	9	-19	-13	N/A
3/31/2018	192	20	N/A	-13	N/A
12/31/2017	191	25	N/A	-16	N/A
9/30/2017	151	-19	N/A	-10	N/A
6/30/2017	152	-23	N/A	4	N/A
3/31/2017	155	-22	N/A	8	N/A
12/31/2016	193	0	N/A	4	N/A
9/30/2016	193	0	N/A	10	N/A
6/30/2016	199	9	N/A	19	N/A
3/31/2016	202	15	N/A	30	N/A
12/31/2015	190	-5	N/A	14	N/A
9/30/2015	184	-12	N/A	8	N/A
6/30/2015	187	-14	N/A	8	N/A
3/31/2015	190	-17	N/A	-4	N/A
12/31/2014	180	-16	N/A	2	N/A
9/30/2014	189	1	N/A	12	N/A
6/30/2014	190	0	N/A	10	N/A
3/31/2014	187	-2	N/A	16	N/A
12/31/2013	179	2	N/A	21	N/A
9/30/2013	170	6	N/A	20	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: EHTH devrait rester non rentable au cours des 3 prochaines années.

Bénéfices vs marché: EHTH devrait rester non rentable au cours des 3 prochaines années.

Croissance élevée des bénéfices: EHTH devrait rester non rentable au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de EHTH ( 6.6% par an) devrait croître plus lentement que le marché de US ( 8.8% par an).

Croissance élevée des revenus: Le chiffre d'affaires de EHTH ( 6.6% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: EHTH devrait être non rentable dans 3 ans.

eHealth Croissance future

Future contrôle des critères 0/6

Informations clés

Mises à jour récentes de la croissance future

Price target decreased by 17% to US$6.67

Consensus EPS estimates fall by 99%, revenue upgraded

Price target decreased by 8.0% to US$7.67

Consensus EPS estimates fall by 31%, revenue upgraded

eHealth, Inc. Reiterate Earnings Guidance for the Full Year Ending December 31, 2024

Price target decreased by 8.2% to US$8.36

Recent updates

Insufficient new directors

Positive Sentiment Still Eludes eHealth, Inc. (NASDAQ:EHTH) Following 25% Share Price Slump

Price target decreased by 17% to US$6.67

Consensus EPS estimates fall by 99%, revenue upgraded

New minor risk - Share price stability

Price target decreased by 8.0% to US$7.67

eHealth, Inc. Announces Retirement of Fran Soistman as Chief Executive Officer

eHealth, Inc. to Report Q2, 2024 Results on Aug 07, 2024

eHealth, Inc.(NasdaqGS:EHTH) dropped from Russell 3000 Index

We Think Some Shareholders May Hesitate To Increase eHealth, Inc.'s (NASDAQ:EHTH) CEO Compensation

eHealth, Inc. Announces CFO Changes

eHealth Inc.: Upside Awaits For Patient Investors

Consensus EPS estimates fall by 31%, revenue upgraded

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

eHealth, Inc. Reiterate Earnings Guidance for the Full Year Ending December 31, 2024

Market Cool On eHealth, Inc.'s (NASDAQ:EHTH) Revenues Pushing Shares 27% Lower

Price target decreased by 8.2% to US$8.36

New major risk - Revenue and earnings growth

eHealth, Inc. (NASDAQ:EHTH) Just Reported, And Analysts Assigned A US$8.36 Price Target

eHealth, Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2024

Full year 2023 earnings released: US$2.37 loss per share (vs US$4.37 loss in FY 2022)

Ehealth, Inc. Unveils "Advisor in the Room" Pilot Program, Bridging the Gap Between Phone and In-Person Support

eHealth, Inc. to Report Q4, 2023 Results on Feb 27, 2024

eHealth: Fairly Valued, But Making Measurable Progress

Sentiment Still Eluding eHealth, Inc. (NASDAQ:EHTH)

New minor risk - Share price stability

Consensus EPS estimates fall by 23%

Price target decreased by 14% to US$9.11

eHealth, Inc. Announces Executive Changes

Consensus EPS estimates fall by 15%, revenue upgraded

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

eHealth, Inc. Provides Earnings Guidance of the Year Ending December 31, 2023

eHealth, Inc. to Report Q3, 2023 Results on Nov 08, 2023

Al Redmer Jr. Joins eHealth's Public Policy Advisory Committee

Independent Chairman of the Board recently bought US$106k worth of stock

Consensus estimates of losses per share improve by 42%

New minor risk - Shareholder dilution

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

eHealth, Inc. Revises Earnings Guidance for the Full Year Ending December 31, 2023

eHealth, Inc. to Report Q2, 2023 Results on Aug 08, 2023

Independent Chairman of the Board recently bought US$83k worth of stock

First quarter 2023 earnings released: US$1.01 loss per share (vs US$1.47 loss in 1Q 2022)

Consensus estimates of losses per share improve by 42%

Price target increased by 20% to US$8.30

Full year 2022 earnings released: US$4.37 loss per share (vs US$4.59 loss in FY 2021)

eHealth, Inc. Announces Randall Livingston Not Stand for Re-Election to the Board of Directors

eHealth, Inc. Welcomes Back Lara Sasken as Senior Vice President, Communications

eHealth, Inc. to Report Q4, 2022 Results on Feb 28, 2023

eHealth, Inc. Provides Earning Guidance for Year Ended December 31, 2022

eHealth, Inc. Appoints Ketan Babaria as SVP and Chief Digital Officer

CEO & Director recently bought US$247k worth of stock

High number of new directors

eHealth, Inc. Announces Management Changes

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

eHealth, Inc. Announces Impairment Charges for the Third Quarter Ended September 30, 2022

eHealth, Inc. to Report Q3, 2022 Results on Nov 07, 2022

eHealth, Inc. Appoints Jana Brown as Senior Vice President and Chief People Officer

Now 27% undervalued after recent price drop

eHealth Appoints Michelle Barbeau Chief Marketing Officer

eHealth appoints Michelle Barbeau CMO

Now 28% undervalued after recent price drop

Consensus revenue estimates fall by 15%

Time To Worry? Analysts Just Downgraded Their eHealth, Inc. (NASDAQ:EHTH) Outlook

Price target decreased to US$10.64

eHealth, Inc. Announces Departure of Phillip Morelock as Chief Digital Officer

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

eHealth, Inc. to Report Q2, 2022 Results on Aug 08, 2022

eHealth falls 9% as stock hits 52-week low

eHealth, Inc. Appoints Gavin Galimi as Senior Vice President, General Counsel and Corporate Secretary